Becton Dickinson & Co (MIL:1BDX)
€ 211.5 -2.1 (-0.98%) Market Cap: 60.75 Bil Enterprise Value: 77.74 Bil PE Ratio: 37.37 PB Ratio: 2.48 GF Score: 64/100

Becton Dickinson and Co To Present At BD Innovate Series Transcript

Dec 11, 2023 / 04:30PM GMT
Release Date Price: €216.5
Operator

Good morning, everyone, and welcome to Becton Dickinson's BD Innovates Series webcast. (Operator Instructions) Later in the call, BD sell-side analysts will have the opportunity to ask questions during the question-and-answer session. Please note that this call is being recorded, and an operator will be standing by should you need any assistance. It is now my pleasure to turn today's program over to Greg Rodetis. Sir, please begin.

Greg Rodetis
Becton, Dickinson and Company - Head of IR

Thank you, operator, and good morning, everyone. I'm Greg Rodetis, Senior Vice President, Treasurer and Head of Investor Relations at BD. I hope everyone enjoyed that short video. I know it's difficult to encapsulate what makes our Pharmaceutical Systems business so unique in 2 minutes. But hopefully, our audience got a flavor for the scale and global nature of this business. With that, thank you for joining us for our third episode of BD Innovates, highlighting Pharm Systems. Today's call will be recorded and will be available for replay on our website, investors.bd.com.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot